Rajnikanth Madabushi

Articles by Rajnikanth Madabushi

PK in Late Phase Trials

ByRajnikanth Madabushi,Jeffry Florian,Fang Li,Christoffer W. Tornoe,Christine Garnett,Hao Zhu,Yaning Wang, PhD,Nitin Mehrotra,Anshu Marathe,Jiang Liu,Venkatesh A. Bhattaram,Pravin R. Jadhav,Jogarao V. Gobburu,Joo-Yeon Lee,Kevin Krudys,Justin C. Earp

February 1st 2012

Applied Clinical Trials

Collecting PK data in late phase trials led to alleviating additional trials, drug approval, and better dosing.

Latest Updated Articles

PK in Late Phase Trials
February 1st 2012

Trending on Applied Clinical Trials Online

Workforce Compression in AI-Driven Clinical Trial Operations

Navigating the Adoption of Biomarker-Informed Trial Enrollment Beyond Oncology

AI Is Moving Faster Than Any Technology Before It

Agentic AI and the Administrative Backbone of Clinical Trials: Why the Operating Model Has to Change First

How Urgent Is the Site Payment Problem, and Is the Industry Finally Taking It Seriously?